companydata.dkcompanydata.dk

EUROLYSE IVS: Financial statements 2023

CVR: 36462191

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

EUROLYSE IVS (CVR 36462191) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2023 report amounted to DKK 100. The solvency ratio was 100%.

Revenue
DKK 0
Equity
DKK 100

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023000100-
2022000100-
2021000100-
2020000100-
2019-00100-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

EUROLYSE IVS: The 2022 annual report is outJun 30, 2023

EUROLYSE IVS has published its annual report for 2022. Revenue came to DKK 0, and the net result was DKK 0.

About EUROLYSE IVS

EUROLYSE IVS was a Danish company of the type Iværksætterselskab based in Frederikssund, founded in 2014. The company has been dissolved on 22 January 2025. The company was registered under the industry Ikke-finansielle holdingselskaber. The company was previously named CRETECSYS IVS. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2024 report amounted to DKK 100.

Source: annual report 2024, Danish Business Authority